Accordingly, we evaluated the populations of circulating stem cells (CD133+) and early EPCs (CD133+/VEGFR2+) in AIS patients, in addition to the functional, chemotactic effect of ACEIs on circulating EPCs in these patients, taking into account aforementioned aspects of stroke pathogenesis. The gene discussed is KDR; the disease is androgen insensitivity syndrome.